Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery
A clinical trial update indicates Huaier Granules are being studied as adjuvant therapy after radical surgery in patients with non-small cel…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma [Phase 2]
This is a Phase 2 clinical trial evaluating neoadjuvant EGFR-targeted therapy in patients with resectable EGFR-mutated lung squamous cell ca…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer [NA]
This clinical trial investigates using patient-derived organoids to guide drug selection for patients with drug-resistant recurrent non-smal…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients
The study aims to use microbiome profiles to predict toxicity from Durvalumab after chemoradiation in stage III non-small cell lung cancer. …
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1) [Phase 2]
A Phase 2 clinical trial evaluating the combination of cabozantinib and atezolizumab for advanced/metastatic non-small cell lung cancer; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection [NA]
A recruiting clinical trial evaluating a novel navigation technique using pulmonary watershed topography to guide lung nodule resection in s…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors [Phase 1]
Phase I clinical study of QLC1101 in patients with advanced solid tumors, including non-small cell lung cancer and colorectal cancer; the st…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: LIFE - Lung Cancer, Immunotherapy, Frailty, Effect
The LIFE trial update describes a study of non-small cell lung cancer examining immunotherapy with attention to frailty and quality-of-life …
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: QOL After SURGERY and ADJUVANT Treatment
A ClinicalTrials.gov update notes a study evaluating quality of life after surgery and adjuvant treatment for non-small cell lung cancer tha…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
This is a clinical cohort study at University Medical Center Groningen evaluating patients with melanoma and non-small cell lung cancer who …
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance [Phase 2]
This clinical trial update summarizes a Phase 2 study evaluating precision immuno-oncology approaches in advanced non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update for KN046 in patients with advanced non-small cell lung cancer; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer
This clinical trial explores neoadjuvant chemoimmunotherapy for stage IIIA (N2) and IIIB non-small cell lung cancer and is not yet recruitin…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating immunosensitized radiotherapy with Evoximab (AK112) plus chemotherapy as neoadjuvant therapy for stage II-III non…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Tomivosertib Combined With Pembrolizumab in Subjects With PD-L1 Positive NSCLC (KICKSTART) [Phase 2]
Phase 2 trial update for tomivosertib in combination with pembrolizumab in PD-L1-positive non-small cell lung cancer (KICKSTART) indicates t…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Lifei Xiaoji Wan Treatment's of Early-stage NSCLC and Its Impact on the Tumor Microenvironment [NA]
The document discusses a clinical trial evaluating Lifei Xiaoji Wan for early-stage non-small cell lung cancer (lung adenocarcinoma) and its…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure [Phase 3]
Phase 3 trial comparing D-1553 tablet to docetaxel injection in KRAS G12C mutation-positive non-small cell lung cancer after prior therapy; …
-
CLINICAL_TRIALS research · 2024-03-07Clinical Trial Update: A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 3]
A phase III trial evaluating reduced frequency pembrolizumab therapy as first-line treatment for advanced non-small cell lung cancer is curr…
-
CLINICAL_TRIALS research · 2024-02-29Clinical Trial Update: Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study [Phase 2]
Phase 2 translational and biomarker study evaluating durvalumab after chemoradiotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2024-02-28Clinical Trial Update: Clinical Trial Assessing the Efficacy of Abscopal Effect Induced by SBRT and Immunotherapy in Advanced NSCLC [Phase 2]
A Phase 2 clinical trial investigating whether combining SBRT and immunotherapy can induce abscopal effects in advanced non-small cell lung …
-
CLINICAL_TRIALS research · 2024-02-01Clinical Trial Update: Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant immunotherapy plus chemotherapy for potentially resectable stage IIIA/IIIB non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2023-10-03Clinical Trial Update: Combining ICI With SBRT or HypoFrx-RT for ES NSCLC [Phase 1, Phase 2]
A clinical trial update evaluating combining immune checkpoint inhibitors with SBRT or hypo-fractionated radiotherapy for non-small cell lun…
-
CLINICAL_TRIALS research · 2019-07-19Clinical Trial Update: Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa
Retrospective epidemiology study assessing ALK rearrangement in non-small cell lung cancer patients in the Middle East and North Africa.
-
CLINICAL_TRIALS research · 2019-05-08Clinical Trial Update: BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer [Phase 2]
A Phase 2 trial update for BATTLE-FL, a front-line biomarker-integrated treatment study in non-small cell lung cancer, completed with posted…
-
CLINICAL_TRIALS research · 2019-03-14Clinical Trial Update: Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating how nintedanib affects pharmacokinetics of ethinylestradiol and levonorgestrel in patients with non-small cell lung…